Privia Health Revenue 2020-2023 | PRVA

Privia Health revenue from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Privia Health Annual Revenue
(Millions of US $)
2023 $1,658
2022 $1,357
2021 $966
2020 $817
2019 $786
Privia Health Quarterly Revenue
(Millions of US $)
2023-12-31 $441
2023-09-30 $417
2023-06-30 $413
2023-03-31 $386
2022-12-31 $364
2022-09-30 $343
2022-06-30 $336
2022-03-31 $314
2021-12-31 $275
2021-09-30 $252
2021-06-30 $226
2021-03-31 $214
2020-12-31 $214
2020-09-30 $207
2020-06-30 $183
2020-03-31 $213
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.147B $1.658B
Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $36.987B 20.31
Inspire Medical Systems (INSP) United States $4.742B 0.00
Axonics (AXNX) United States $3.435B 0.00
10x Genomics (TXG) United States $3.214B 0.00
IRhythm Technologies (IRTC) United States $3.075B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.923B 0.00
Enovis (ENOV) United States $2.836B 21.02
Hims & Hers Health (HIMS) United States $2.769B 0.00
Azenta (AZTA) United States $2.768B 155.58
Schrodinger (SDGR) United States $1.685B 0.00
Omnicell (OMCL) United States $1.414B 48.89
Phreesia (PHR) United States $1.241B 0.00
Standard BioTools (LAB) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.664B 0.00
Definitive Healthcare (DH) United States $0.640B 0.00
Talkspace (TALK) United States $0.484B 0.00
Clover Health Investments (CLOV) United States $0.452B 0.00
Health Catalyst (HCAT) United States $0.401B 0.00
Pulmonx (LUNG) United States $0.340B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.299B 0.00
Butterfly Network (BFLY) United States $0.201B 0.00
P3 Health Partners (PIII) United States $0.199B 0.00
Outset Medical (OM) United States $0.160B 0.00
American Well (AMWL) United States $0.145B 0.00
TruBridge (TBRG) United States $0.133B 7.15
Augmedix (AUGX) United States $0.115B 0.00
MSP Recovery (LIFW) United States $0.113B 0.00
111 (YI) China $0.108B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.077B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
EUDA Health Holdings (EUDA) Singapore $0.058B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
Movano (MOVE) United States $0.041B 0.00
CareCloud (CCLD) United States $0.037B 0.00
Akili (AKLI) United States $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Cue Health (HLTH) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00